K. Iwanaga
发表
H. Takubo,
T. Taniguchi,
K. Iwanaga,
2020,
Xenobiotica; the fate of foreign compounds in biological systems.
Y. Ikada,
M. Kakemi,
K. Iwanaga,
2003
.
Y. Tabata,
T. Kushibiki,
Ryuji Tomoshige,
2006,
Journal of biomaterials science. Polymer edition.
M. Miyazaki,
K. Iwanaga,
K. Morimoto,
2003,
Drug metabolism and pharmacokinetics.
Y. Ikada,
Y. Tabata,
H. Katsumata,
1999
.
P. Watkins,
E. Schuetz,
E. Dees,
2008,
Drug Metabolism and Disposition.
K. Iwanaga,
K. Hosohata,
H. Matsuoka,
2020,
Journal of clinical hypertension.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2018,
Therapeutics and clinical risk management.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2011,
Drug metabolism and pharmacokinetics.
N. Mise,
F. Kayama,
K. Iwanaga,
2019,
Toxicology and industrial health.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2012,
Archives of pharmacal research.
M. Miyazaki,
J. Nagai,
K. Iwanaga,
2020,
Scientific Reports.
P. Watkins,
E. Schuetz,
E. Dees,
2007
.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2020,
Therapeutics and clinical risk management.
K. Iwanaga,
M. Uchida,
S. Ueno,
2020
.
M. Kakemi,
K. Iwanaga,
K. Morimoto,
2000,
Pharmaceutica acta Helvetiae.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2012,
Drug metabolism and pharmacokinetics.
K. Thummel,
M. Cheesman,
K. Iwanaga,
2006
.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2013,
Xenobiotica; the fate of foreign compounds in biological systems.
T. Taniguchi,
K. Iwanaga,
Y. Nomura,
2020,
Xenobiotica; the fate of foreign compounds in biological systems.
R. Sakakibara,
M. Ishiguro,
K. Iwanaga,
1998,
Bioscience, biotechnology, and biochemistry.
K. Iwanaga,
K. Hosohata,
A. Inada,
2019,
Clinical Drug Investigation.
M. Miyazaki,
M. Kakemi,
M. Kawai,
2012,
International journal of pharmaceutics.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2010,
International journal of pharmaceutics.
Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin.
Y. Ikada,
Y. Tabata,
H. Katsumata,
2001,
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
Yang Dai,
Kenneth E Thummel,
Kazunori Iwanaga,
2004,
Biochemical pharmacology.
H. Katsumata,
M. Kakemi,
K. Iwanaga,
2001,
Drug development and industrial pharmacy.
Y. Nakai,
M. Kakemi,
K. Iwanaga,
1998,
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
Y. Tabata,
M. Kakemi,
K. Iwanaga,
2002,
Journal of controlled release : official journal of the Controlled Release Society.
K. Iwanaga,
K. Hosohata,
A. Inada,
2019,
Clinical Drug Investigation.
H. Yamada,
K. Iwanaga,
K. Hosohata,
2018,
Journal of clinical pharmacy and therapeutics.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2018,
Therapeutics and clinical risk management.
K. Iwanaga,
K. Hosohata,
A. Inada,
2019,
International journal of toxicology.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2018,
The Journal of international medical research.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2013,
Drug development and industrial pharmacy.
S. Yamashita,
N. Oku,
M. Kakemi,
2003,
Journal of controlled release : official journal of the Controlled Release Society.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2015,
European Journal of Drug Metabolism and Pharmacokinetics.
K. Iwanaga,
K. Hosohata,
A. Inada,
2019,
Journal of clinical pharmacy and therapeutics.
K. Iwanaga,
K. Hosohata,
A. Inada,
2018,
Advances in Nephropathy.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2013,
Archives of Pharmacal Research.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2013,
Archives of Pharmacal Research.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2019,
Journal of pharmaceutical health care and sciences.
Furanocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-Glycoprotein
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2010,
Drug Metabolism and Disposition.
S. Takai,
K. Iwanaga,
K. Hosohata,
2019,
International journal of molecular sciences.
K. Iwanaga,
K. Hosohata,
Takashi Doi,
2020,
Clinical medicine insights. Case reports.
S. Yamashita,
M. Nango,
N. Oku,
1997
.
S. Yamashita,
N. Oku,
Y. Namba,
1999,
Journal of pharmaceutical sciences.
Y. Ikada,
Y. Tabata,
H. Katsumata,
2000,
The Journal of pharmacy and pharmacology.
M. Miyazaki,
T. Kushibiki,
M. Kakemi,
2006,
Biological & pharmaceutical bulletin.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2014,
Biological & pharmaceutical bulletin.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2012,
Archives of Pharmacal Research.
M. Miyazaki,
S. Yoneda,
M. Kakemi,
2011,
Biological & pharmaceutical bulletin.
K. Thummel,
M. Cheesman,
K. Iwanaga,
2006
.
M. Miyazaki,
M. Kakemi,
K. Iwanaga,
2015
.
Y. Ikada,
Y. Tabata,
M. Kakemi,
2003,
Journal of microencapsulation.
Y. Tabata,
T. Kushibiki,
Ryuji Tomoshige,
2006,
Journal of controlled release : official journal of the Controlled Release Society.
K. Iwanaga,
K. Hosohata,
A. Inada,
2020,
Die Pharmazie.
K. Iwanaga,
K. Hosohata,
M. Uchida,
2021,
Current clinical pharmacology.
S. Takai,
K. Iwanaga,
K. Hosohata,
2018,
International journal of molecular sciences.
G. Barrows,
K. Iwanaga,
K. Hosohata,
1983,
Environmental health perspectives.
K. Iwanaga,
K. Hosohata,
A. Inada,
2018,
Advances in Nephropathy.